According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -3,03ย โฌ. In 2022 the company made an earnings per share (EPS) of -2,79ย โฌ a decrease over its 2021 EPS that were of -2,41ย โฌ.